![Jason Myers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Myers
Direttore/Membro del Consiglio presso
Venn Biosciences Corp.
Profilo
Jason W.
Myers was the founder of ArcherDX LLC, founded in 2013, where the titles held included President, Chief Executive Officer & Director from 2015 to 2020.
Dr. Myers currently serves as Director at Venn Biosciences Corp.
since 2022.
Former positions include Director at Invitae Corp.
from 2020 to 2021; Independent Director at IsoPlexis Corp.
from 2021 to 2023; President & Director at Singular Genomics Systems, Inc.; Chief Executive & Financial Officer, Director at GenapSys, Inc. from 2021 to 2022; Chief Scientific Officer at Universal Display Corp.
from 2013 to 2015; and Chief Scientific Officer at QIAGEN Beverly LLC.
Education includes undergraduate studies at Colorado State University and a doctorate from Stanford University School of Medicine.
Posizioni attive di Jason Myers
| Società | Posizione | Inizio |
|---|---|---|
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Operates as a life sciences company unlocking the value of glycoproteomic for the development of transformational healthcare solutions by using AI | Direttore/Membro del Consiglio | 04/10/2022 |
Precedenti posizioni note di Jason Myers
| Società | Posizione | Fine |
|---|---|---|
| ISOPLEXIS CORPORATION | Direttore/Membro del Consiglio | 21/03/2023 |
GenapSys, Inc.
 GenapSys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops as a DNA-sequencing technology that enables fast, accurate and low cost genetic research & testing services | Amministratore Delegato | 01/09/2022 |
| INVITAE CORPORATION | Direttore/Membro del Consiglio | 05/07/2021 |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Fondatore | 02/10/2020 |
| UNIVERSAL DISPLAY CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Formazione di Jason Myers
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Universal Display Corp.
 Universal Display Corp. Electronic Production EquipmentElectronic Technology Engages in research, development and commercialization of organic light emitting diode (OLED), technologies and materials | Electronic Technology |
QIAGEN Beverly LLC
 QIAGEN Beverly LLC BiotechnologyHealth Technology Manufactures enzymes and biological reagents | Health Technology |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
GenapSys, Inc.
GenapSys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops as a DNA-sequencing technology that enables fast, accurate and low cost genetic research & testing services | Commercial Services |
IsoPlexis Corp.
 IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services Develops software solutions for investigating cancer treatment | Technology Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singular Genomics Systems, Inc.
 Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Operates as a life sciences company unlocking the value of glycoproteomic for the development of transformational healthcare solutions by using AI | Health Technology |
